Originally published by our sister publication Pharmacy Practice News
Hospital and health-system pharmacies are still awaiting the National Institute for Occupational Safety and Health (NIOSH) official release of its updated list of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, which has been in draft form since 2020. But on April 27, 2023, they got at least some guidance when NIOSH released the updated versions of the list’s two companion documents: